An important part of participating in a project such as this is ensuring that you understand how the collected data will be used and why community input is so valuable and fundamentally vital.
Dr. Jo Daniels looks at coping strategies to help in adjusting to the new 'normal' as we resume our daily activities. Based on cognitive behavourial therapy techniques, these simple steps can help us all to feel a little bit more in control as life moves on.
A team of researchers based in the USA, UK, Germany, Switzerland and Japan sought to examine the results of the SENSCIS trial to assess the safety and tolerability of nintedanib in people with SSc-ILD.
SRUK’s co-funded project with World Scleroderma Foundation seeking to improve the Combined Response Index in SSc Score.
Date: Wed 2nd September 2020
Back To Life - The Psychological Journey Towards a 'New Normal'
Date: Wed 26th August 2020
Findings of nintedanib's safety and tolerability published
Date: Fri 21st August 2020